BIOINFORMATICS EXPLORATION OF ROYAL JELLY-DERIVED PEPTIDES OF HONEYBEE AS POTENTIAL INHIBITORS OF SELECTED MAJOR VIRULENCE FACTORS IN NEISSERIA GONORRHOEAE
DOI:
https://doi.org/10.22159/ajpcr.2026v19i1.57041Keywords:
Neisseria gonorrhoeae, antibiotic resistance, royal jelly, antimicrobial peptides, immunoinformatics, drug discoveryAbstract
Objectives: Neisseria gonorrhoeae has become a substantial worldwide health threat as antibiotic resistance increases. The urgent need for alternative treatments is underscored by the lack of a vaccine and the increasing prevalence of drug-resistant strains. Royal jelly (RJ), a beehive product rich in proteins and bioactive compounds, has garnered attention for its latent therapeutic applications. RJ antimicrobial properties have driven the exploration of new approaches to combat drug-resistant pathogens.
Methods: Bioinformatics approaches were employed for modeling RJ derived-peptide and to analyze the structure, physicochemical properties, antimicrobial potential, and docking interactions of the three peptides (Apisimin, royalisin (defensin-1), and Major RJ protein 1 (MRJP-1) with the major outer membrane protein (PorB) and Type IV major pilin protein PilE from N. gonorrhoeae membrane protein.
Results: Distinct motifs were identified for every peptide modeled from RJ by structural analysis. Peptides showed diverse physicochemical characteristics and could impact their biological functions. Machine learning predicted antimicrobial activity for defensin-1 and MRJP-1. Docking simulations suggested stronger interactions between PorB and the peptides compared to PilE. Defensin-1 could be an important peptide in developing novel antimicrobial agents for targeting N. gonorrhoeae. Nonetheless, in vitro investigations are necessary.
Conclusion: This study underscores the imminent potential of immunoinformatics tools in discovering innovative antimicrobial solutions, including membrane disruption, and emphasizes their role and possible routes of action in developing alternative treatments to overcome this persistent pathogen.
Downloads
References
1. Lin EY, Adamson PC, Klausner JD. Epidemiology, treatments, and vaccine development for antimicrobial-resistant Neisseria gonorrhoeae: Current strategies and future directions. Drugs. 2021;81(10):1153-69. doi: 10.1007/s40265-021-01530-0, PMID 34097283
2. Yeshanew AG, Geremew RA. Neisseria gonorrhoae and their antimicrobial susceptibility patterns among symptomatic patients from Gondar town, North West Ethiopia. Antimicrob Resist Infect Control. 2018;7:85. doi: 10.1186/s13756-018-0376-3, PMID 30026943
3. Scurtu LG, Jinga V, Simionescu O. Fascinating molecular and immune escape mechanisms in the treatment of STIs (syphilis, gonorrhea, chlamydia, and herpes simplex). Int J Mol Sci. 2022;23(7):3550. doi: 10.3390/ijms23073550, PMID 35408911
4. McIntosh ED. Development of vaccines against the sexually transmitted infections gonorrhoea, syphilis, chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus. Ther Adv Vaccin Immunother. 2020;8:2515135520923887. doi: 10.1177/2515135520923887, PMID 32647779
5. Soltan MA, Elbassiouny N, Gamal H, Elkaeed EB, Eid RA, Eldeen MA, et al. In silico prediction of a multitope vaccine against Moraxella catarrhalis: Reverse vaccinology and immunoinformatics. Vaccines (Basel). 2021;9(6):669. doi: 10.3390/vaccines9060669, PMID 34207238
6. Venkatesan P. WHO 2020 report on the antibacterial production and development pipeline. Lancet Microbe. 2021;2(6):e239. doi: 10.1016/ S2666-5247(21)00124-5, PMID 35544169
7. He Y, Zhang S, Zhang Y, Wu B, Xue Y, Ye C, et al. Distinct patterns of host adherence by Neisseria gonorrhoeae isolated from experimental gonorrhea. Can J Infect Dis Med Microbiol. 2021;2021:7865405. doi: 10.1155/2021/7865405, PMID 34093925
8. Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat Rev Microbiol. 2018;16(4):226-40. doi: 10.1038/ nrmicro.2017.169, PMID 29430011
9. Park HS, Wolfgang M, Koomey M. Modification of type IV pilus-associated epithelial cell adherence and multicellular behavior by the PilU protein of Neisseria gonorrhoeae. Infect Immun. 2002;70(7):3891-903. doi: 10.1128/IAI.70.7.3891-3903.2002, PMID 12065533
10. Hung MC, Christodoulides M. The biology of Neisseria adhesins. Biology. 2013;2(3):1054-109. doi: 10.3390/biology2031054, PMID 24833056
11. Walker E, van Niekerk S, Hanning K, Kelton W, Hicks J. Mechanisms of host manipulation by Neisseria gonorrhoeae. Front Microbiol. 2023;14:1119834. doi: 10.3389/fmicb.2023.1119834, PMID 36819065
12. Cole JG, Jerse AE. Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops. PLoS One. 2009;4(12):e8108. doi: 10.1371/journal.pone.0008108, PMID 19956622
13. Edwards JL, Apicella MA. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev. 2004;17(4):965-81. doi: 10.1128/ CMR.17.4.965-981.2004, PMID 15489357
14. Mavrogiorgos N, Mekasha S, Yang Y, Kelliher MA, Ingalls RR. Activation of NOD receptors by Neisseria gonorrhoeae modulates the innate immune response. Innate Immun. 2014;20(4):377-89. doi: 10.1177/1753425913493453, PMID 23884094
15. Ghosh S, Jung C. Chemical composition and nutritional value of royal jelly samples obtained from honey bee (Apis mellifera) hives fed on oak and rapeseed pollen patties. Insects. 2024;15(3):141. doi: 10.3390/ insects15030141, PMID 38535337
16. Pratami DK, Alfifah SC, Islam I, Sahlan M, Soekanto SA. Analysis of propolis stingless bee bioactive compounds from several regions in Indonesia. Int J Appl Pharm. 2024;16:77-82. doi: 10.22159/ ijap.2024v16i3.14
17. Pitu W, Felix Z, Olivia AH, Irma E, Nurdiana, Julia M, et al. Phytochemical analysis and effectiveness of stingless bee (Geniotrigona thoracica) propolis on matrix metalloproteinase-8 levels in periodontal therapy. Int J Appl Pharm. 2024;16(2):22-8.
18. Buttstedt A, Moritz RF, Erler S. Origin and function of the major royal jelly proteins of the honeybee (Apis mellifera) as members of the yellow gene family. Biol Rev Camb Philos Soc. 2014;89(2):255-69. doi: 10.1111/brv.12052, PMID 23855350
19. Ramanathan AN, Nair AJ, Sugunan VS. A review on Royal Jelly proteins and peptides. J Funct Foods. 2018;44:255-64. doi: 10.1016/j. jff.2018.03.008
20. Bogdanov S. Royal jelly, bee brood: composition, health, medicine. Sci Bee J. 2011;3:8-19.
21. Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: A comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev. 2017;2017:1259510. doi: 10.1155/2017/1259510, PMID 28814983
22. Fratini F, Cilia G, Mancini S, Felicioli A. Royal Jelly: An ancient remedy with remarkable antibacterial properties. Microbiol Res. 2016;192:130-41. doi: 10.1016/j.micres.2016.06.007, PMID 27664731
23. Park MJ, Kim BY, Park HG, Deng Y, Yoon HJ, Choi YS, et al. Major royal jelly protein 2 acts as an antimicrobial agent and antioxidant in royal jelly. J Asia Pac Entomol. 2019;22(3):684-9. doi: 10.1016/j. aspen.2019.05.003
24. Coutinho D, Karibasappa SN, Mehta DS. Royal jelly antimicrobial activity against periodontopathic bacteria. J Interdiscip Dent. 2018;8(1):18. doi: 10.4103/jid.jid_72_17
25. Ovchinnikov S, Kinch L, Park H, Liao Y, Pei J, Kim DE, et al. Large-scale determination of previously unsolved protein structures using evolutionary information. eLife. 2015;4:e09248. doi: 10.7554/ eLife.09248, PMID 26335199
26. Söding J. Big-data approaches to protein structure prediction. Science. 2017;355(6322):248-9. doi: 10.1126/science.aal4512, PMID 28104854
27. Ovchinnikov S, Park H, Varghese N, Huang PS, Pavlopoulos GA, Kim DE, et al. Protein structure determination using metagenome sequence data. Science. 2017;355(6322):294-8. doi: 10.1126/science. aah4043, PMID 28104891
28. van Breugel M, Silva IR, Andreeva A. Structural validation and assessment of AlphaFold2 predictions for centrosomal and centriolar proteins and their complexes. Commun Biol. 2022;5(1):312. doi: 10.1038/s42003-022-03269-0, PMID 35383272
29. Xu D, Zhang Y. Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J. 2011;101(10):2525-34. doi: 10.1016/j.bpj.2011.10.024, PMID 22098752
30. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. Protein identification and analysis tools on the Expasy server. In: Walker JM, editor. The Proteomics Protocols Handbook. United States: Humana Press; 2005. p. 571-607. doi: 10.1385/1-59259- 890-0:571
31. Wiederstein M, Sippl MJ. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35(Web Server issue):W407-10. doi: 10.1093/ nar/gkm290, PMID 17517781
32. Morozov V, Rodrigues CH, Ascher DB. CSM-toxin: A web-server for predicting protein toxicity. Pharmaceutics. 2023;15(2):431. doi: 10.3390/pharmaceutics15020431, PMID 36839752
33. Sabatini AG, Marcazzan GL, Fiorenza Caboni M, Bogdanov S, Bicudo De Almeida-Muradian L. Quality and standardization of Royal Jelly. J Api Prod Api Med Sci. 2009;1:1-6.
34. Rudel T, Schmid A, Benz R, Kolb HA, Lang F, Meyer TF. Modulation of Neisseria porin (PorB) by cytosolic ATP/GTP of target cells: Parallels between pathogen accommodation and mitochondrial endosymbiosis. Cell. 1996;85(3):391-402. doi: 10.1016/S0092-8674(00)81117-4, PMID 8616894
35. Li S, Tao L, Yu X, Zheng H, Wu J, Hu F. Royal jelly proteins and their derived peptides: Preparation, properties, and biological activities. J Agric Food Chem. 2021;69(48):14415-27. doi: 10.1021/acs. jafc.1c05942, PMID 34807598
36. Buttstedt A. The role of 10-hydroxy-Δ2-decenoic acid in the formation of fibrils of the major royal jelly protein 1/apisimin/24- methylenecholesterol complex isolated from honey bee (Apis mellifera) royal jelly. Eur J Entomol. 2022;119:448-53. doi: 10.14411/ eje.2022.047
37. Fontana R, Mendes MA, De Souza BM, Konno K, César LM, Malaspina O, et al. Jelleines: A family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera). Peptides. 2004;25(6):919-28. doi: 10.1016/j.peptides.2004.03.016, PMID 15203237
38. Fujiwara S, Imai J, Fujiwara M, Yaeshima T, Kawashima T, Kobayashi K. A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J Biol Chem. 1990;265(19):11333-7. doi: 10.1016/S0021-9258(19)38596-5, PMID 2358464
39. Leiva-Sabadini C, Alvarez S, Barrera NP, Schuh CM, Aguayo S. Antibacterial effect of honey-derived exosomes containing antimicrobial peptides against oral streptococci. Int J Nanomedicine. 2021;16:4891-900. doi: 10.2147/IJN.S315040, PMID 34321877
40. Álvarez S, Contreras-Kallens P, Aguayo S, Ramírez O, Vallejos C, Ruiz J, et al. Royal jelly extracellular vesicles promote wound healing by modulating underlying cellular responses. Mol Ther Nucleic Acids. 2023;31:541-52. doi: 10.1016/j.omtn.2023.02.008, PMID 36895953
41. Moriyama T, Ito A, Omote S, Miura Y, Tsumoto H. Heat resistant characteristics of major royal jelly protein 1 (MRJP1) oligomer. PLoS One. 2015;10(5):e0119169. doi: 10.1371/journal.pone.0119169, PMID 26020775
42. Bilal B, Azim MK. Nematicidal activity of “major royal jelly protein”- containing glycoproteins from Acacia honey. Exp Parasitol. 2018;192:52-9. doi: 10.1016/j.exppara.2018.07.011, PMID 30040959
43. Bucekova M, Majtan J. The MRJP1 honey glycoprotein does not contribute to the overall antibacterial activity of natural honey. Eur Food Res Technol. 2016;242(4):625-9. doi: 10.1007/s00217-016-2665-5
44. Vezeteu TV, Bobis O, Moritz RF, Buttstedt A. Food to some, poison to others - honeybee royal jelly and its growth inhibiting effect on European Foulbrood bacteria. Microbiologyopen. 2017;6:e00397.
45. Brudzynski K, Sjaarda C. Lannigan, R. MRJP1-containing glycoproteins isolated from honey, a novel antibacterial drug candidate with broad spectrum activity against multi-drug resistant clinical isolates. Front Microbiol. 2015;6:711.
46. Cabrera MP, Baldissera G, Silva-Gonçalves LC, Souza BM, Riske KA, Palma MS, et al. Combining experimental evidence and molecular dynamic simulations to understand the mechanism of action of the antimicrobial octapeptide jelleine-I. Biochemistry. 2014;53:4857-4868.
47. Zaky AA, Simal-Gandara J, Eun JB, Shim JH, Abd El-Aty AM. Bioactivities, Applications, safety, and health benefits of bioactive peptides from Food and By-Products: A review. Front Nutr. 2022;8:815640. doi: 10.3389/fnut.2021.815640, PMID 35127796
48. Gotfried MH. Clarithromycin (Biaxin) extended-release tablet: A therapeutic review. Expert Rev Anti Infect Ther. 2003;1(1):9-20. doi: 10.1586/14787210.1.1.9, PMID 15482099
Published
How to Cite
Issue
Section
Copyright (c) 2025 MARYAM SALEH ALHUMAIDI
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.